Should a biopsy be recommended to confirm metastatic disease in women with breast cancer?

被引:40
作者
Amir, Eitan [1 ]
Clemons, Mark [2 ]
机构
[1] Princess Margaret Hosp, Div Med Oncol, Toronto, ON M4X 1K9, Canada
[2] Ottawa Hosp, Ctr Canc, Div Med Oncol, Ottawa, ON, Canada
关键词
ESTROGEN; BONE;
D O I
10.1016/S1470-2045(09)70295-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:933 / 935
页数:3
相关论文
共 14 条
[1]   Biopsy confirmation of metastatic breast cancer: interim results of a prospective biopsy study [J].
Amir, E. ;
Freedman, O. ;
Simmons, C. ;
Miller, N. ;
Geddie, W. ;
DeBorja, A. ;
Maung, H. ;
Gianfelice, D. ;
Murphy, K. ;
Clemons, M. .
BREAST CANCER RESEARCH, 2009, 11 :S20-S20
[2]   Discordance between Receptor Status in Primary and Metastatic Breast Cancer: an Exploratory Study of Bone and Bone Marrow Biopsies [J].
Amir, E. ;
Ooi, W. S. ;
Simmons, C. ;
Kahn, H. ;
Christakis, M. ;
Popovic, S. ;
Kalina, M. ;
Chesney, A. ;
Singh, G. ;
Clemons, M. .
CLINICAL ONCOLOGY, 2008, 20 (10) :763-768
[3]   VARIABILITY OF ESTROGEN RECEPTORS IN METASTATIC BREAST-CANCER [J].
BRENNAN, MJ ;
DONEGAN, WL ;
APPLEBY, DE .
AMERICAN JOURNAL OF SURGERY, 1979, 137 (02) :260-262
[4]   Technical pitfalls potentially affecting diagnoses in immunohistochemistry [J].
Bussolati, G. ;
Leonardo, E. .
JOURNAL OF CLINICAL PATHOLOGY, 2008, 61 (11) :1184-1192
[5]   PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer [J].
Dehdashti, Farrokh ;
Mortimer, Joanne E. ;
Trinkaus, Kathryn ;
Naughton, Michael J. ;
Ellis, Matthew ;
Katzenellenbogen, John A. ;
Welch, Michael J. ;
Siegel, Barry A. .
BREAST CANCER RESEARCH AND TREATMENT, 2009, 113 (03) :509-517
[6]   Development and Characterization of Clinical-Grade 89Zr-Trastuzumab for HER2/neu ImmunoPET Imaging [J].
Dijkers, Eli C. F. ;
Kosterink, Jos G. W. ;
Rademaker, Anna P. ;
Perk, Lars R. ;
van Dongen, Guus A. M. S. ;
Bart, Joost ;
de Jong, Johan R. ;
de Vries, Elisabeth G. E. ;
Lub-de Hooge, Marjolijn N. .
JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (06) :974-981
[7]   ESTROGEN AND PROGESTERONE-RECEPTOR CONCORDANCE BETWEEN PRIMARY AND RECURRENT BREAST-CANCER [J].
LI, BDL ;
BYSKOSH, A ;
MOLTENI, A ;
DUDA, RB .
JOURNAL OF SURGICAL ONCOLOGY, 1994, 57 (02) :71-77
[8]   Reliance on hormone receptor assays of surgical specimens may compromise outcome in patients with breast cancer [J].
Mann, GB ;
Fahey, VD ;
Feleppa, F ;
Buchanan, MR .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) :5148-5154
[9]   Circulating tumor cells in breast cancer:: Correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity [J].
Müller, V ;
Stahmann, N ;
Riethdorf, S ;
Rau, T ;
Zabel, T ;
Goetz, A ;
Janicke, F ;
Pantel, K .
CLINICAL CANCER RESEARCH, 2005, 11 (10) :3678-3685
[10]   Quantitative imaging of estrogen receptor expression in breast cancer with PET and 18F-fluoroestradiol [J].
Peterson, Lanell M. ;
Mankoff, David A. ;
Lawton, Thomas ;
Yagle, Kevin ;
Schubert, Erin K. ;
Stekhova, Svetlana ;
Gown, Allen ;
Link, Jeanne M. ;
Tewson, Timothy ;
Krohn, Kenneth A. .
JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (03) :367-374